85 related articles for article (PubMed ID: 35982128)
21. High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation.
Xu J; Zhou Y; Zhang J; Chen Y; Zhuang R; Liu T; Cai W
Clin Chim Acta; 2012 Aug; 413(15-16):1284-7. PubMed ID: 22546611
[TBL] [Abstract][Full Text] [Related]
22. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
23. Of the Nine Cytidine Deaminase-Like Genes in Arabidopsis, Eight Are Pseudogenes and Only One Is Required to Maintain Pyrimidine Homeostasis in Vivo.
Chen M; Herde M; Witte CP
Plant Physiol; 2016 Jun; 171(2):799-809. PubMed ID: 27208239
[TBL] [Abstract][Full Text] [Related]
24. Identification and functional characterization of a novel cytidine deaminase in a gastropod abalone, Haliotis diversicolor supertexta.
Wu L; Wu X; Zhu B; Cao X
Dev Comp Immunol; 2009 May; 33(5):709-17. PubMed ID: 19150626
[TBL] [Abstract][Full Text] [Related]
25. Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation.
Mercier C; Raynal C; Dahan L; Ortiz A; Evrard A; Dupuis C; Blesius A; Duluc M; Franceschini F; Giacometti S; Salas S; Milano G; Favre R; Seitz JF; Ciccolini J
Pharmacogenet Genomics; 2007 Oct; 17(10):841-4. PubMed ID: 17885621
[TBL] [Abstract][Full Text] [Related]
26. Structural, kinetic, and mutational studies of the zinc ion environment in tetrameric cytidine deaminase.
Johansson E; Neuhard J; Willemoës M; Larsen S
Biochemistry; 2004 May; 43(20):6020-9. PubMed ID: 15147186
[TBL] [Abstract][Full Text] [Related]
27. Determination of common genetic variants in cytidine deaminase (CDA) gene in Indian ethnic population.
Iyer SN; Ankala A; Singhal RS; Hegde MR
Gene; 2013 Jul; 524(1):35-9. PubMed ID: 23612254
[TBL] [Abstract][Full Text] [Related]
28. Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.
Mameri H; Bièche I; Meseure D; Marangoni E; Buhagiar-Labarchède G; Nicolas A; Vacher S; Onclercq-Delic R; Rajapakse V; Varma S; Reinhold WC; Pommier Y; Amor-Guéret M
Clin Cancer Res; 2017 Apr; 23(8):2116-2126. PubMed ID: 27601591
[No Abstract] [Full Text] [Related]
29. [Ethnic differences of genetic polymorphisms in cancer chemotherapy].
Saijyo N
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1072-5. PubMed ID: 18633243
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human cytidine deaminase: expression, purification, and characterization.
Vincenzetti S; Cambi A; Neuhard J; Garattini E; Vita A
Protein Expr Purif; 1996 Sep; 8(2):247-53. PubMed ID: 8812871
[TBL] [Abstract][Full Text] [Related]
31. Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels.
Mameri H; Buhagiar-Labarchède G; Fontaine G; Corcelle C; Barette C; Onclercq-Delic R; Beauvineau C; Mahuteau-Betzer F; Amor-Guéret M
Cell Mol Life Sci; 2022 Aug; 79(8):465. PubMed ID: 35925417
[TBL] [Abstract][Full Text] [Related]
32. High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects.
Ebrahem Q; Mahfouz RZ; Ng KP; Saunthararajah Y
Oncotarget; 2012 Oct; 3(10):1137-45. PubMed ID: 23087155
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase.
Shafiee M; Griffon JF; Gosselin G; Cambi A; Vincenzetti S; Vita A; Eriksson S; Imbach JL; Maury G
Biochem Pharmacol; 1998 Nov; 56(9):1237-42. PubMed ID: 9802336
[TBL] [Abstract][Full Text] [Related]
34. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.
Carpi FM; Vincenzetti S; Micozzi D; Vita A; Napolioni V
Mol Biol Rep; 2010 Oct; 37(7):3363-8. PubMed ID: 19941076
[TBL] [Abstract][Full Text] [Related]
35. Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening.
Costanzi S; Vilar S; Micozzi D; Carpi FM; Ferino G; Vita A; Vincenzetti S
ChemMedChem; 2011 Aug; 6(8):1452-8. PubMed ID: 21598398
[TBL] [Abstract][Full Text] [Related]
36. Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.
Abraham A; Varatharajan S; Abbas S; Zhang W; Shaji RV; Ahmed R; Abraham A; George B; Srivastava A; Chandy M; Mathews V; Balasubramanian P
Pharmacogenomics; 2012 Feb; 13(3):269-82. PubMed ID: 22304580
[TBL] [Abstract][Full Text] [Related]
37. Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA.
Gemble S; Ahuja A; Buhagiar-Labarchède G; Onclercq-Delic R; Dairou J; Biard DS; Lambert S; Lopes M; Amor-Guéret M
PLoS Genet; 2015 Jul; 11(7):e1005384. PubMed ID: 26181065
[TBL] [Abstract][Full Text] [Related]
38. CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population.
Carpi FM; Vincenzetti S; Ubaldi J; Pucciarelli S; Polzonetti V; Micozzi D; Mignini F; Napolioni V
Pharmacogenomics; 2013 May; 14(7):769-81. PubMed ID: 23651026
[TBL] [Abstract][Full Text] [Related]
39. Modulation of human cytidine deaminase by specific aminoacids involved in the intersubunit interactions.
Vincenzetti S; Quadrini B; Mariani P; De Sanctis G; Cammertoni N; Polzonetti V; Pucciarelli S; Natalini P; Vita A
Proteins; 2008 Jan; 70(1):144-56. PubMed ID: 17640070
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution.
Johansson E; Mejlhede N; Neuhard J; Larsen S
Biochemistry; 2002 Feb; 41(8):2563-70. PubMed ID: 11851403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
